Vimarsana
Biggest News Aggregation in the World

Ivan Borrello News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ivan Borrello. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ivan Borrello Today - Breaking & Trending Today

New therapies are making multiple myeloma more survivable - Vimarsana News

New therapies are making multiple myeloma more survivable

New drugs have made it possible to live much longer with the disease, and some scientists even see a possible cure down the road.

Fighting cancer with medical breakthroughs, mRNA and immunotherapies - Vimarsana News

Fighting cancer with medical breakthroughs, mRNA and immunotherapies

Cancer researchers at Tampa General Hospital and Moffitt Cancer Center are optimistic about breakthroughs in medicine, treatments, immunotherapies, and mRNA vaccines to treat some cancers.

JHU spinout WindMIL Therapeutics expands to Philly, adds two new executives - Vimarsana News

JHU spinout WindMIL Therapeutics expands to Philly, adds two new executives

The Baltimore-based cancer immunotherapy startup is growing its team.

World-Renowned Myeloma Expert, Dr. Ivan Borrello, Joins TGH Cancer Institute to Lead Its Bone Marrow Transplant (BMT)and Cell Therapies Program - Vimarsana News

World-Renowned Myeloma Expert, Dr. Ivan Borrello, Joins TGH Cancer Institute to Lead Its Bone Marrow Transplant (BMT)and Cell Therapies Program

/PRNewswire/ -- Tampa General Hospital is announcing its appointment of Dr. Ivan Borrello to the TGH Cancer Institute. Borrello is a world-class translational...

WindMIL Therapeutics Appoints Dr. Kimberly Noonan as Chief - Vimarsana News

WindMIL Therapeutics Appoints Dr. Kimberly Noonan as Chief

WindMIL Therapeutics Appoints Dr. Kimberly Noonan as Chief Science & Technology Officer May 06, 2021 07:00 ET | Source: WindMIL Therapeutics WindMIL Therapeutics Philadelphia, Pennsylvania, UNITED STATES PHILADELPHIA and BALTIMORE, May 06, 2021 (GLOBE NEWSWIRE) -- WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs ®) for cancer immunotherapy, today announced the appointment of Co-Founder Kimberly Noonan, PhD, MPH, to Executive Vice President, Chief Science & Technology Officer. In this role, Dr. Noonan...